The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Malignant pleural mesothelioma is a highly aggressive tumor associated with asbestos
exposure. There are few effective treatment options for mesothelioma, and patients have a …

Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

Malignant pleural mesothelioma (MPM) is an aggressive disease arising in pleural cell
lining and is associated with asbestos exposure. Today, there is a rising incidence of MPM …

Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Malignant pleural mesothelioma (MM) is a highly aggressive tumor characterized by a poor
prognosis. Although its carcinogenesis mechanism has not been strictly understood, about …

Simple Summary Mesothelioma is a deadly disease with a dismal prognosis. Since its
discovery, mesothelin, a cell surface protein, has been a promising biomarker and …

Simple Summary Malignant pleural mesothelioma (MPM) is an aggressive and still
incurable cancer. There is an urgent need to identify effective and reliable tools for detecting …

In 2011, SCOEL classified RCF as a secondary genotoxic carcinogen and supported a
practical threshold. Inflammation was considered the predominant manifestation of RCF …

Introduction Malignant pleural mesothelioma (MPM) is difficult to diagnose. An accurate
blood biomarker could prompt specialist referral or be deployed in future screening. In …